TABLE 2.
No. of independent experiments | Vaccinea | WT agent used in challengeb | Total no. of mice challenged | % survivalc |
% sterile immunityd | |
---|---|---|---|---|---|---|
Acute infection | Chronic infection | |||||
11 | batA KO | B. mallei ATCC 23344 | 99 | 73 | 56 | 0 |
Naive | 94 | 4 | 2 | 0 | ||
8 | batA KO | B. pseudomallei 1026b | 82 | 71 | 67 | 62 |
Naive | 74 | 0 | 0 | 0 | ||
4 | batA KO | B. pseudomallei K96243 | 33 | 100 | 85 | 57 |
Naive | 27 | 11 | 4 | 0 |
Mice were vaccinated intratracheally with 104 CFU of the batA KO mutant strain using a Microsprayer.
Thirty to 45 days postvaccination, mice were back-challenged intratracheally with lethal doses of WT bacteria (∼10 LD50 of WT B. mallei ATCC 23344 and ∼5 LD50 of B. pseudomallei 1026b and K96243) using a Microsprayer device. Age- and weight-matched naive mice were used as controls.
Acute infection, 1 to 10 days postchallenge; chronic infection, 11 to 55 days postchallenge.
The livers, spleens, and lungs of survivors were collected, homogenized, diluted, and plated onto agar medium to determine whether the tissues were colonized with WT bacteria.